Navigation Links
NeuroSigma Announces Debut of Its Monarch eTNS System in Canada
Date:6/21/2013

and Monarch eTNS are trademarks of NeuroSigma, Inc.

About NeuroSigma, Inc.


NeuroSigma is a Los Angeles-based medical device company established to develop early stage technologies with the potential to transform medical practice and patients' lives.  Currently, NeuroSigma is focused on neuromodulation therapies and has amassed significant intellectual property licensed on an exclusive basis from the University of California, Los Angeles (UCLA), including TNS therapies for epilepsy, depression, post-traumatic stress disorder (PTSD) and attention-deficit hyperactivity disorder (ADHD). Please visit www.neurosigma.com for more corporate information and www.monarch-etns.com for more information on the Monarch eTNS System.

Forward-Looking Safe Harbor Statement:

This press release contains forward-looking statements, including but not limited to, research and development outcomes, efficacy, adverse reactions, market and product potential, product availability and other statements regarding our eTNS™ and sTNS™ systems.  These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company's expectations and projections. Risks and uncertainties include, among other things, general industry and medical device market conditions; technological advances and patents attained by competitors; challenges inherent in the research and development and regulatory processes; challenges related to new product marketing, such as the unpredictability of market acceptance for new medical device products; inconsistency of treatment results among patients; potential difficulties in manufacturing a new product; general economic conditions; and governmental laws a
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeuroSigma Launches Dedicated Website to Introduce Its Monarch eTNS System for Epilepsy and Depression
2. NeuroSigma Receives Health Canada Approval for Its Monarch eTNS System for the Treatment of Drug-Resistant Epilepsy and Major Depressive Disorder
3. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
4. NeuroSigma Awarded Fast Track SBIR Grant by the NIH for Development of Implantable sTNS System for Drug Resistant Epilepsy
5. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
6. NeuroSigma Receives CE Certification
7. NeuroSigma Receives Global Quality Control Certification
8. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
9. JDRF Announces Two Partnerships to Develop Stable, Pumpable Glucagon to Support Advanced Generation Artificial Pancreas Systems
10. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
11. Valeant Pharmaceuticals Announces Exercise Of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Asterias Biotherapeutics Inc. (OTCBB: ASTY) has received ... to initiate a Phase 1/2a clinical trial of its ... injury.  The approved trial follows the successful completion of ... is designed to assess safety and activity of escalating ... cord injuries, the first targeted indication for AST-OPC1 and ...
(Date:8/26/2014)... STATESVILLE, N.C., Aug. 26, 2014  Kewaunee Scientific Corporation ... its first quarter ended July 31, 2014. ... sales of $32,003,000 in the first quarter last year. ... per diluted share, as compared to net earnings of ... quarter of the prior year. However, both sales and ...
(Date:8/26/2014)... 26, 2014 Research and Markets ... Meter Industry Report 2014 " report to their ... Report 2014 is a professional and in-depth study on ... The report provides a basic overview of ... structure. The glucose meter market analysis is provided for ...
Breaking Medicine Technology:Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5Kewaunee Scientific Reports Results for First Quarter 2Kewaunee Scientific Reports Results for First Quarter 3Kewaunee Scientific Reports Results for First Quarter 4Kewaunee Scientific Reports Results for First Quarter 5Kewaunee Scientific Reports Results for First Quarter 6Global Glucose Meter Industry Report 2014 2Global Glucose Meter Industry Report 2014 3
(Date:8/27/2014)... Casey Diekman, assistant professor of mathematical sciences ... to gain greater insight into the biological clock that ... harmonized the behavior of humans and all other mammals ... of light and dark experienced each day and with ... related to natural patterns of sleep/wake behavior which, when ...
(Date:8/27/2014)... Time to Play Golf, a fast-growing ... , With 80-degree temperatures and only partially clouded skies, ... (TTPGolf) Inaugural Outing. Around 50 golfers showed up to duel ... beautiful Heron Glen Golf Course in Ringoes, New Jersey. , ... to be having a great time. Birdies were dropping and ...
(Date:8/27/2014)... August 27, 2014 President Obama is ... immigration. A White House initiative that supplies green ... undocumented immigrants would also open a pathway to Social ... , Access to work authorization would add new ... the program is the target of proposals to cut ...
(Date:8/27/2014)... The use of ESAs to treat ... may eliminate the need for blood transfusion and associated ... webinar, Dr. Zanhua Yi, board certified in hematology, oncology, ... necessity of erythropoiesis-stimulating agents (ESAs) in the treatment of ... Food and Drug Administration (FDA) has approved three ESAs ...
(Date:8/27/2014)... Michael A. Bottar has been ... Best Lawyers In America© for the practice areas of ... - Plaintiffs." , Bottar received his undergraduate degree from ... of Syracuse University College of Law where is an ... of the Syracuse Law Review Survey of New York ...
Breaking Medicine News(10 mins):Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 3Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 4Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:The Senior Citizens League (TSCL) Warns: White House Action On Immigration Could Give Social Security To Known Illegals 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3Health News:Michael A. Bottar Selected For Inclusion In The Best Lawyers In America© 2015 2
... 25 - "We are excited about,the strong efforts in ... facility," said Judie Brown, president of American Life,League., ... nation,with 287 surgical and medical abortion facilities across the ... abortion operation in the,Denver suburb of Stapleton and local ...
... stem cells that differentiate into bone appears to cause regeneration ... strategy for osteoporosis, according to a report in the February ... by researchers from Massachusetts General Hospital (MGH) and the Harvard ... medication used to treat bone marrow cancer improved bone density ...
... while eating out in the New Year, SAN ... the New Year,s resolution list. But for the thousands ... is not always,easy. Today, American Express issued its Tastemaker ... best San Francisco restaurants where diners,can get a fresh, ...
... 25 3.5 million lives could be,saved over the ... and treatment measures in the 30 hardest hit countries ... the World Economic,Forum. Additionally, rapid scale-up would increase annual ... prevent 672 million malaria cases, and,free up 427,000 needed ...
... of teenagers may have metabolic syndrome, a clustering of risk ... and diabetes in adulthood. This shocking statistic represents some of ... in children and adolescents a necessary starting point for ... in youth than it has been in adults. , With ...
... Full Year 2007 Revenue of Approximately $154 million, Announces Full ... ... SAN DIEGO, Jan. 25 NuVasive, Inc. (Nasdaq:,NUVA), a medical ... for the spine, today announced,preliminary unaudited financial results for the ...
Cached Medicine News:Health News:Turning on adult stem cells may help repair bone 2Health News:Eating Healthy in the New Year? American Express Tastemakers Dish on the Top San Francisco Restaurants for Grabbing a Healthy Bite 2Health News:Eating Healthy in the New Year? American Express Tastemakers Dish on the Top San Francisco Restaurants for Grabbing a Healthy Bite 3Health News:Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds 2Health News:Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds 3Health News:Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds 4Health News:Metabolic syndrome affects nearly 1 in 10 US teens 2Health News:Metabolic syndrome affects nearly 1 in 10 US teens 3Health News:NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 2Health News:NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 3
Frequency 55 Toric XR is a great option for those with high levels of astigmatism...
... SofLens66 Toric lens are fit ... current soft toric lens wearers who ... with the health and convenience of ... want the convenience of contact lenses; ...
The Heine C series binocular loupes offer extremely low weight (46g), crisp views, and quality German construction in an affordable instrument....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
Medicine Products: